医学
肝细胞癌
脂肪性肝炎
脂肪肝
阿司匹林
内科学
疾病
减肥
肥胖
胃肠病学
作者
Naomi F. Lange,Pompilia Radu,Jean‐François Dufour
标识
DOI:10.1016/j.jhep.2021.07.025
摘要
In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing. Preventive strategies are needed to counteract this trend. In this review, we provide an overview of the evidence on preventive strategies in NAFLD-associated HCC. We consider the impact of lifestyle factors such as weight loss, physical activity, smoking, dietary patterns and food items, including coffee and alcohol, on both HCC and NAFLD/NASH. Furthermore, evidence on chemopreventive treatments, including aspirin, antidiabetic treatments and statins is summarised. The role of adjuvant therapies for tertiary prevention of HCC is briefly reviewed.
科研通智能强力驱动
Strongly Powered by AbleSci AI